Relationship between different subpopulations of circulating CD4+ T-lymphocytes and microvascular structural alterations in humans

American Journal of Hypertension

Volumn 30, Issue 1, 2017, Pages 51-60

  De Ciuceis, Carolina ^a   Rossini, Claudia ^a   Airò, Paolo ^a   Scarsi, Mirko ^a   Tincani, Angela ^a   Tiberio, Guido Alberto Massimo ^a   Piantoni, Silvia ^a   Porteri, Enzo ^a   Solaini, Leonardo ^a   Duse, Sarah ^a   Semeraro, Francesco ^a   Petroboni, Beatrice ^a   Mori, Luigi ^a   Castellano, Maurizio ^a   Gavazzi, Alice ^a   Rosei, Claudia Agabiti ^a   Rosei, Enrico Agabiti ^a   Rizzoni, Damiano ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Division of Internal Medicine   (Italy)

Author keywords

Blood pressure; Capillaries; Hypertension; Immune system; Lymphocytes; Microcirculation; Vascular biology

Indexed keywords

CD4 ANTIGEN; C REACTIVE PROTEIN;

ADULT; AGED; ARTERY DISSECTION; ARTERY RESISTANCE; ARTICLE; BLOOD SAMPLING; CAPILLARY DENSITY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYPERTENSION; LASER DOPPLER FLOWMETRY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; RETINAL ARTERIOLE; SUBCUTANEOUS FAT; T LYMPHOCYTE SUBPOPULATION; VIDEO MICROSCOPY; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; ELECTIVE SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERTENSION; MALE; MICROVESSELS; MIDDLE AGED;

EID: 85014885151     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpw102     Document Type: Article

References (50)

1. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009; 9:418-428.
2. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38:581-587.
3. Leibowitz A, Schiffrin EL. Immune mechanisms in hypertension. Curr Hypertens Rep 2011; 13:465-472.
4. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension 2011; 57:132-140.
5. Harrison DG, Vinh A, Lob H, Madhur MS. Role of the adaptive immune system in hypertension. Curr Opin Pharmacol 2010; 10:203-207.
6. Taleb S, Tedgui A, Mallat Z. Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med 2008; 263:489-499.
7. Schiffrin EL. Immune mechanisms in hypertension and vascular injury. Clin Sci (Lond) 2014; 126:267-274.
8. Virdis A, Schiffrin EL. Vascular inflammation: A role in vascular disease in hypertension? Curr Opin Nephrol Hypertens 2003; 12:181-187.
9. Schiffrin EL. T lymphocytes: A role in hypertension? Cur Opin Nephrol Hypertens 2010; 19:181-186.
10. Viel EC, Lemarie CA, Benkirane K, Paradis P, Schiffrin EL. Immune regulation and vascular inflammation in genetic hypertension. Am J Physiol Heart Circ Physiol 2010; 298:H938-H944.
11. Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011; 57:469-476.
12. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204:2449-2460.
13. Virdis A, Savoia C, Grassi G, Lembo G, Vecchione C, Seravalle G, Taddei S, Volpe M, Rosei EA, Rizzoni D. Evaluation of microvascular structure in humans: A 'state-of-The-art' document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension. J Hypertens 2014; 32:2120-2129; discussion 2129.
14. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
15. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61:181-186.
16. Mulvany MJ, Hansen OK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43:854-864.
17. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Rosei EA. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with noninsulin-dependent diabetes mellitus. Circulation 2001; 103:1238-1244.
18. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti-Rosei E. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28:785-790.
19. Harazny JM, Ritt M, Baleanu D, Ott C, Heckmann J, Schlaich MP, Michelson G, Schmieder RE. Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension 2007; 50:623-629.
20. Ritt M, Harazny JM, Ott C, Schlaich MP, Schneider MP, Michelson G, Schmieder RE. Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens 2008; 26:1427-1434.
21. Rizzoni D, Porteri E, Duse S, De Ciuceis C, Rosei CA, La Boria E, Semeraro F, Costagliola C, Sebastiani A, Danzi P, Tiberio GA, Giulini SM, Docchio F, Sansoni G, Sarkar A, Rosei EA. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-tolumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry. J Hypertens 2012; 30:1169-1175.
22. Harazny JM, Raff U, Welzenbach J, Ott C, Ritt M, Lehmann M, Michelson G, Schmieder RE. New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens 2011; 29:777-782.
23. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999; 34:655-658.
24. De Ciuceis C, Rossini C, Porteri E, La Boria E, Corbellini C, Mittempergher F, Di Betta E, Sarkar A, Agabiti Rosei C, Casella C, Nascimbeni R, Rezzani R, Rodella LF, Borsani E, Enrico Agabiti Rosei E, Rizzoni D. Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery. Blood Press 2013; 22:165-172.
25. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33:998-1001.
26. Kassan M, Wecker A, Kadowitz P, Trebak M, Matrougui K. CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension. J Hypertens 2013; 31:1939-1943.
27. Kassan M, Galan M, Partyka M, Trebak M, Matrougui K. Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler Thromb Vasc Biol 2011; 31:2534-2542.
28. Schiffrin EL. Immune mechanisms in hypertension: how do T-regulatory lymphocytes fit in? J Hypertens 2013; 31:1944-1945.
29. Zhang J, Crowley SD. Role of T lymphocytes in hypertension. Curr Opin Pharmacol 2015; 21:14-19.
30. Youn JC, Yu HT, Lim BJ, Koh MJ, Lee J, Chang DY, Choi YS, Lee SH, Kang SM, Jang Y, Yoo OJ, Shin EC, Park S. Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension 2013; 62:126-133.
31. Duftner C, Seiler R, Klein-Weigel P, Gobel H, Goldberger C, Ihling C, Fraedrich G, Schirmer M. High prevalence of circulating CD4+CD28-T-cells in patients with small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2005; 25:1347-1352.
32. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101:2883-2888.
33. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, Mannarino E. CD4+CD28-T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004; 109:2744-2748.
34. Madhur MS, Harrison DG. Senescent T cells and hypertension: new ideas about old cells. Hypertension 2013; 62:13-15.
35. Schiffrin EL. Immune modulation of resistance artery remodelling. Basic Clin Pharmacol Toxicol 2012; 110:70-72.
36. Schiffrin EL. The immune system: role in hypertension. Can J Cardiol 2013; 29:543-548.
37. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91:281-291.
38. Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42:31-38.
39. Cheng X, Ding Y, Xia C, Tang T, Yu X, Xie J, Liao M, Yao R, Chen Y, Wang M, Liao YH. Atorvastatin modulates Th1/Th2 response in patients with chronic heart failure. J Card Fail 2009; 15:158-162.
40. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010; 55:500-507.
41. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127:89-97.
42. Wang Q, Zhai X, Chen X, Lu J, Zhang Y, Huang Q. Dysregulation of circulating CD4+CXCR5+ T cells in type 2 diabetes mellitus. APMIS 2015; 123:146-151.
43. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2010; 298:R1136-R1142.
44. Crowley SD, Frey CW, Gould SK, Griffiths R, Ruiz P, Burchette JL, Howell DN, Makhanova N, Yan M, Kim HS, Tharaux PL, Coffman TM. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol 2008; 295:F515-F524.
45. Rodriguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001; 59:2222-2232
46. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD. Regulatory T cells suppress innate immunity in kidney ischemiareperfusion injury. J Am Soc Nephrol 2009; 20:1744-1753.
47. Chan CT, Sobey CG, Lieu M, Ferens D, Kett MM, Diep H, Kim HA, Krishnan SM, Lewis CV, Salimova E, Tipping P, Vinh A, Samuel CS, Peter K, Guzik TJ, Kyaw TS, Toh BH, Bobik A, Drummond GR. Obligatory role for B cells in the development of angiotensin II-dependent hypertension. Hypertension 2015; 66:1023-1033.
48. Carnevale D, Pallante F, Fardella V, Fardella S, Iacobucci R, Federici M, Cifelli G, De Lucia M, Lembo G. The angiogenic factor PlGF mediates a neuroimmune interaction in the spleen to allow the onset of hypertension. Immunity 2014; 41:737-752.
49. Airo P, Scarsi M. Targeting CD4+CD28-T cells by blocking CD28 costimulation. Trends Mol Med 2013; 19:1-2.
50. Scarsi M, Zanotti C, Chiarini M, Imberti L, Piantoni S, Frassi M, Tincani A, Airo P. Reduction of peripheral blood T cells producing IFN-γ and IL-17 after therapy with abatacept for rheumatoid arthritis. Clin Exp Rheumatol 2014; 32:204-210.